December 14, 2024: IPO Updates, Nestlé Controversy, Sensex Rally, and Key Global News {update}

IPO Corner

• Mobikwik, Vishal Mega Mart, IKS Health: Check subscription status updates.

Corporate News

• Nestlé Baby Food Controversy: No violation in sugar content, says JP Nadda in Lok Sabha.

Allu Arjun Arrest

• Stampede Case:
  • Telangana HC granted interim bail to actor Allu Arjun.
  • Incident occurred during the Pushpa 2 premiere.
  • Victim’s husband reportedly ready to withdraw the case.

Middle East Updates

• Insight: Assad’s final hours in Syria revealed deception and despair.
• Freed Prisoners: Released Syrians return to dire conditions.
• Illicit Trade: Discovery of a large Syrian drug lab uncovers hidden networks.

Economic News

• Switzerland-India Tax Treaty: Switzerland suspends MFN clause, leading to higher dividend tax.
• Sensex Rally: Up 5,000 points since November lows—mutual fund advice expected.
• Tamil Nadu Subsidies: Interest subsidy announced to modernize textile mills.

Sports Highlights

• ICC Champions Trophy 2025: India will not tour Pakistan; hybrid model approved.
• India vs Australia: Key players to watch in the 3rd Test at Gabba.

Key Personalities

• Gukesh Dommaraju: Young chess champion divides opinions in the chess world.
• Imad Wasim: Retires from international cricket.

Regional News

• Tamil Nadu Rains: Heavy rainfall triggers waterlogging and red alerts.
• Odisha: State emphasizes land use restrictions under Vasundhara Yojana.

Business Insights

• Meesho Growth: Small-town buyers and Gen Z drive 35% growth in 2024.
• Gold Prices: Set for the best performance in 10 years.

Breaking News

• Rs 6,000 Crore Ponzi Scam: Allegations against a BJP worker in Gujarat.
• Hyderabad Nizam’s Contribution: Donation of 5,000 kg gold surfaces in archives.

Global News

• Iran Drone Carriers: Satellite images reveal advanced military projects.
• Indian Students in Canada: Tragic deaths reported.

For Advertising, Guest Posting, Newsletter Inserts please contact [email protected]. For general enquiries contact [email protected].